Spots Global Cancer Trial Database for other cancer
Every month we try and update this database with for other cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Examining the Long-Term Risks of Oophorectomy | NCT00655447 | Coronary Heart ... Stroke Breast Cancer Ovarian Cancer Cancer Hip Fracture Death | 30 Years - 55 Years | Parker, William H., M.D. | ||
| A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care | NCT06397651 | Breast Cancer Lung Cancer Prostate Cancer Colorectal Canc... Other Cancer | Complement Theo... Digital applica... | 21 Years - 64 Years | Complement Theory Inc. | |
| Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals | NCT03736746 | Other Cancer | Motivational In... | 18 Years - | Dana-Farber Cancer Institute | |
| A Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer | NCT03721926 | Other Cancer | Usual Care Geriatric Oncol... | 65 Years - | Massachusetts General Hospital | |
| Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy | NCT05176860 | Lung Cancer Liver Cancer Breast Cancer Other Cancer | CBCT Imaging | 19 Years - | Varian, a Siemens Healthineers Company | |
| A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care | NCT06397651 | Breast Cancer Lung Cancer Prostate Cancer Colorectal Canc... Other Cancer | Complement Theo... Digital applica... | 21 Years - 64 Years | Complement Theory Inc. | |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | NCT04340024 | Nasopharyngeal ... Prostate Cancer Other Cancer | 21 Years - 99 Years | National Cancer Centre, Singapore | ||
| Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) | NCT03674047 | Other Cancer | ruxolitinib | 18 Years - 75 Years | Massachusetts General Hospital | |
| Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention | NCT03638453 | Other Cancer | PediCARE Usual Care | 1 Day - 17 Years | Dana-Farber Cancer Institute | |
| Multimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors | NCT03967379 | Other Cancer | Mobile App + en... Enhanced Standa... | 18 Years - | Massachusetts General Hospital | |
| Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) | NCT06103669 | Breast Cancer Oligoprogressiv... Head and Neck C... Sarcoma Other Cancer | Ablative local ... | 18 Years - | University of California, Davis | |
| Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals | NCT03736746 | Other Cancer | Motivational In... | 18 Years - | Dana-Farber Cancer Institute | |
| Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly | NCT03609177 | Other Cancer | Clinician Commu... Advance Care Pl... Video Declarati... | 65 Years - | Dana-Farber Cancer Institute | |
| Symptom Management Implementation of Patient Reported Outcomes in Oncology | NCT03850912 | Other Cancer Gastrointestina... Thoracic Cancer Gynecologic Can... | eSyM App Usage SASS Questionna... | 18 Years - | Dana-Farber Cancer Institute | |
| OPTimizing Treatment Focused Genetic Testing IN Cancer | NCT04066361 | Breast Cancer Ovarian Cancer Pancreatic Canc... Prostate Cancer | Chatbot Video Education | 18 Years - | Dana-Farber Cancer Institute | |
| The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy | NCT04591431 | Breast Cancer Gastrointestina... Non Small Cell ... Other Cancer | Erlotinib Trastuzumab Trastuzumab emt... Pertuzumab Lapatinib Everolimus Vemurafenib Cobimetinib Alectinib Brigatinib Palbociclib Ponatinib Vismogedib Itacitinib Ipatasertib Entrectinib Atezolizumab Nivolumab Ipilimumab Pemigatinib Oncology Drugs Pralsetinib Selpercatinib Talazoparib Tepotinib Alpelisib | 18 Years - | Fondazione per la Medicina Personalizzata | |
| Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation | NCT03244826 | Other Cancer | Shared Care Standard Care | 18 Years - | Dana-Farber Cancer Institute | |
| Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS) | NCT06103669 | Breast Cancer Oligoprogressiv... Head and Neck C... Sarcoma Other Cancer | Ablative local ... | 18 Years - | University of California, Davis | |
| Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions | NCT03160274 | Pheochromocytom... Paraganglioma Inherited Cance... Associated Cond... Kidney Neoplasm... Bone Cancer Thyroid Neoplas... Other Cancer | Genetic screeni... | - | The University of Texas Health Science Center at San Antonio | |
| Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals | NCT03736746 | Other Cancer | Motivational In... | 18 Years - | Dana-Farber Cancer Institute | |
| SHARE (Sharing Goals and Preferences) Study | NCT03392090 | Other Cancer | More Good Days ... | 18 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
